Baker Brothers Life Sciences Capital (GP), LLC Insider Trading $INCY INCYTE CORP
Get free email notifications about insider trading for Baker Brothers Life Sciences Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Brothers Life Sciences Capital (GP), LLC. Baker Brothers Life Sciences Capital (GP), LLC is Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Baker Brothers Life Sciences Capital (GP), LLC in INCYTE CORP
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Baker Brothers Life Sciences Capital (GP), LLC: Director
Holdings: 8,929,705 shares
Current Value: $1,055,312,537
Latest Transaction: Sep 28 2009
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Brothers Life Sciences Capital (GP), LLC in INCYTE CORP
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IBPI, AUXL, GHDX, IDRA, INCY, NRGN, SGEN, GEVA, NPRO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 28 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | D | 11.22 | 33,130,000 | 371,668,905 | 0 | |
| Sep 28 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | D | 11.22 | 42,509,000 | 476,887,217 | 0 | |
| Sep 28 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | A | 8.78 | 124,687,000 | 1,094,751,860 | 124,687,000 | |
| Sep 28 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Grant | A | 6.75 | 1,848,200 | 12,475,350 | 8,929,705 | 7.1 M to 8.9 M (+26.10 %) |
Page: 1